Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

XePOHCAS - Xenon by Inhalation for Post Out of Hospital Cardiac Arrest Syndrome

NCT03176186 is registered in ClinicalTrials.gov with Invero Pharma, Inc. as lead sponsor.

NCT NCT03176186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03176186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
XePOHCAS - Xenon by Inhalation for Post Out of Hospital Cardiac Arrest Syndrome
Lead sponsor
Invero Pharma, Inc.
Phase
Phase 3
Overall status
Not yet recruiting
Start date
March 31, 2026
Completion date
May 31, 2030
Enrollment
1,436 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

post-cardiac arrest syndrome